Communications Medicine (Jun 2024)

Real-time motion-enabling positron emission tomography of the brain of upright ambulatory humans

  • Nanda K. Siva,
  • Christopher Bauer,
  • Colson Glover,
  • Alexander Stolin,
  • Sonia Chandi,
  • Helen Melnick,
  • Gary Marano,
  • Benjamin Parker,
  • MaryBeth Mandich,
  • James W. Lewis,
  • Jinyi Qi,
  • Si Gao,
  • Kaylee Nott,
  • Stan Majewski,
  • Julie A. Brefczynski-Lewis

DOI
https://doi.org/10.1038/s43856-024-00547-2
Journal volume & issue
Vol. 4, no. 1
pp. 1 – 12

Abstract

Read online

Abstract Background Mobile upright PET devices have the potential to enable previously impossible neuroimaging studies. Currently available options are imagers with deep brain coverage that severely limit head/body movements or imagers with upright/motion enabling properties that are limited to only covering the brain surface. Methods In this study, we test the feasibility of an upright, motion-compatible brain imager, our Ambulatory Motion-enabling Positron Emission Tomography (AMPET) helmet prototype, for use as a neuroscience tool by replicating a variant of a published PET/fMRI study of the neurocorrelates of human walking. We validate our AMPET prototype by conducting a walking movement paradigm to determine motion tolerance and assess for appropriate task related activity in motor-related brain regions. Human participants (n = 11 patients) performed a walking-in-place task with simultaneous AMPET imaging, receiving a bolus delivery of F18-Fluorodeoxyglucose. Results Here we validate three pre-determined measure criteria, including brain alignment motion artifact of less than <2 mm and functional neuroimaging outcomes consistent with existing walking movement literature. Conclusions The study extends the potential and utility for use of mobile, upright, and motion-tolerant neuroimaging devices in real-world, ecologically-valid paradigms. Our approach accounts for the real-world logistics of an actual human participant study and can be used to inform experimental physicists, engineers and imaging instrumentation developers undertaking similar future studies. The technical advances described herein help set new priorities for facilitating future neuroimaging devices and research of the human brain in health and disease.